Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Bronchopulmonary Dysplasia
- Adrenal Insufficiency
- Multisystem Inflammatory Syndrome in Children (MIS-C)
- Skin Infection
- Hypokalemia
- Kawasaki Disease
- Pulmonary Arterial Hypertension
- Arrythmia
- Asthma in Children
- "Attention Deficit Hyperactivity Disorder"
- Pain
- Hemophilia
- Hyperphosphatemia
- Coagulation Disorder
- Urinary Tract Infections in Children
- Pneumonia
- Coronavirus Infection (COVID-19)
- Insomnia
- Menorrhagia
- Down Syndrome
- Edema
- Fibrinolysis; Hemorrhage
- Heart Failure
- Hypertension
- Primary Hyperaldosteronism
- Type
- Observational
- Design
- Observational Model: OtherTime Perspective: Prospective
Participation Requirements
- Age
- Younger than 20 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04278404
- Collaborators
- The Emmes Company, LLC
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Investigators
- Principal Investigator: Chi Hornik Duke Clinical Research Institute
Get Well Soon